Antibodies specific for pβ-Cat52 and core region detected β-catenin/TCF4 binding predominantly in CRC, but not antibodies for N and C terminal β-catenin epitopes (Fig. 4A and Suppl. Here, TCF4 is linked to colorectal carcinoma.